Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Obstructive Lung Diseases

Free Subscription 10.08.2026 1 Allergy 1 Am J Respir Crit Care Med 3 Ann Allergy Asthma Immunol 2 Arch Bronconeumol 1 BMJ 1 Curr Opin Pulm Med 3 Eur Respir J 3 J Allergy Clin Immunol 1 J Asthma 2 Pediatr Pulmonol 1 Pneumologie 1 Proc Natl Acad Sci U S A 4 Respir Med 1 Respir Res 1 Rev Mal Respir 3 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. CHAE W, An J, Lee CE, Kim SY, et al
   Plasma Metabolomes Identify Distinct Asthma Metabotypes: Findings From the COREA Cohort.
   Allergy. 2026 Aug 5. doi: 10.1111/all.70469.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

2. MARTINEZ-GARCIA MA, Chang AB, Chotirmall SH, Tino G, et al
   The Renaissance of Bronchiectasis.
   Am J Respir Crit Care Med. 2026 Aug 8:aamag413. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Ann Allergy Asthma Immunol

3. COPPOLA S, Agizza A, Iorio RF, Carucci L, et al
   Obesity, Asthma and Allergy Triangle: The Solution could be the Diet.
   Ann Allergy Asthma Immunol. 2026 Aug 6:S1081-1206(26)00383.
   PubMed         Abstract available
   
   
4. MORACZEWSKI J, Bacharier LB
   Is Remission a Meaningful Outcome in Asthma?
   Ann Allergy Asthma Immunol. 2026 Aug 5:S1081-1206(26)00381.
   PubMed         Abstract available
   
   
5. LIM JV, Lipworth B, Menzella F, Usmani O, et al
   Improved peripheral airway reactance is associated with clinical remission following biologic therapy in severe asthma.
   Ann Allergy Asthma Immunol. 2026 Aug 3:S1081-1206(26)00364.
   PubMed         Abstract available
   
   

   
   Arch Bronconeumol

6. HARTMAN JE, Caspar Anthony S, Klooster K, Slebos DJ, et al
   Minimal Important Difference of FEV(1) and FVC in COPD Patients Undergoing Bronchoscopic Lung Volume Reduction.
   Arch Bronconeumol. 2026;62:542-547.
   PubMed         Abstract available
   
   
7. CABALLEROS LAM M, Pujols Leon PR, Inarrairaegui M, Ezponda A, et al
   Comparison of Lung Cancer Screening Programs in Liver Transplant Recipients and the General Population.
   Arch Bronconeumol. 2026 Apr 9:S0300-2896(26)00124.
   PubMed         Abstract available
   
   

   
   BMJ

8. PORTELA GT, Wang SV, Suissa S, Schneeweiss S, et al
   Comparative effectiveness of azithromycin versus roflumilast in patients with chronic obstructive pulmonary disease: emulated target trial.
   BMJ. 2026;394:e100111.
   PubMed         Abstract available
   
   

   
   Curr Opin Pulm Med

9. FORIS V, Cho MH, Boueiz A
   Genetic variants in pulmonary hypertension associated with chronic obstructive pulmonary disease.
   Curr Opin Pulm Med. 2026 Apr 28. doi: 10.1097/MCP.0000000000001275.
   PubMed         Abstract available
   
   

   
   Eur Respir J

10. VAN DIJK M, Mooren KJM, van Beurden-Moeskops W, Heller-Baan R, et al
    Fentanyl or morphine for persistent dyspnoea in COPD: a multicentre randomised crossover trial.
    Eur Respir J. 2026;68:2501431.
    PubMed         Abstract available
    
    
11. ELBEHAIRY AF, Faisal A, McIsaac H, James MD, et al
    Postural relief of dyspnoea is associated with improved neuromechanical coupling in patients with advanced COPD.
    Eur Respir J. 2026;68:2501348.
    PubMed         Abstract available
    
    
12. MATHESON AM, Willmering MM, Dournes G, Humbert M, et al
    Novel translational pulmonary MRI in paediatrics: a review of the past 10 years.
    Eur Respir J. 2026;68:2501619.
    PubMed         Abstract available
    
    

    
    J Allergy Clin Immunol

13. KELLY MS, Huang CY, Kim M, Haghnazari D, et al
    Nasal microbiome and phageome profiles are associated with prospective respiratory viral infection risk in school-age children.
    J Allergy Clin Immunol. 2026;158:408-420.
    PubMed         Abstract available
    
    
14. GABRYSZEWSKI SJ, Hirabayashi K, Botdorf M, Maltenfort M, et al
    Incidence of autoimmune diseases in children with atopy treated with dupilumab.
    J Allergy Clin Immunol. 2026;158:533-541.
    PubMed         Abstract available
    
    
15. SELLE A, Yero A, Moon JJ, Campbell DJ, et al
    A regulatory T cell-biased IL-2 mutein inhibits the development of allergen-specific Th2 cells and allergic asthma.
    J Allergy Clin Immunol. 2026 Aug 6:S0091-6749(26)00560.
    PubMed         Abstract available
    
    

    
    J Asthma

16. AL-QEREM W, Jarab A, Al Bawab AQ, Eberhardt J, et al
    Parental Numeracy Skills and Pediatric Asthma Outcomes in Jordan: A Cross-Sectional Study of Asthma-Related Quality of Life.
    J Asthma. 2026 Aug 3:1-19. doi: 10.1080/02770903.2026.2712840.
    PubMed         Abstract available
    
    

    
    Pediatr Pulmonol

17. HANSON AE, Ennett S, Rogerson CM
    Association of Social Drivers of Health With Hospitalizations for Pediatric Asthma.
    Pediatr Pulmonol. 2026;61:e71775.
    PubMed         Abstract available
    
    
18. KNOPEK A, Fabinyi H, Zach V, Beliveau A, et al
    Feasibility and Measurement Quality of Home-Based Smartphone Spirometry in Children With Suspected Asthma: A Multicentre, Prospective Study.
    Pediatr Pulmonol. 2026;61:e71768.
    PubMed         Abstract available
    
    

    
    Pneumologie

19. LAMPERT S, Hubner I, Joest M, Kahnert K, et al
    [Prescribing biologics to adults with asthma - step by step].
    Pneumologie. 2026 Aug 6. doi: 10.1055/a-2867-1834.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

20. CHOU WC, Hsu M, Wrobel JA, Holley-Guthrie E, et al
    T cell-intrinsic AIM2 exacerbates lung inflammation in OVA-LPS- and HDM-induced asthma models.
    Proc Natl Acad Sci U S A. 2026;123:e2520215123.
    PubMed         Abstract available
    
    

    
    Respir Med

21. MILGER K, Dorscheid D, Gessner C, Hilberg O, et al
    Early and continued asthma control up to week 24 in patients with severe, uncontrolled asthma treated with tezepelumab: Initial results of the real-world ASCENT study.
    Respir Med. 2026 Aug 6:109075. doi: 10.1016/j.rmed.2026.109075.
    PubMed         Abstract available
    
    
22. MARTINI M, Cecchi L, Musarra A, Jaubashi K, et al
    Expert consensus on the Management of Mild and Moderate Asthma.
    Respir Med. 2026 Aug 6:109078. doi: 10.1016/j.rmed.2026.109078.
    PubMed         Abstract available
    
    
23. VASSILEVA SM, Khamas SS, Dyhre-Petersen N, Principe S, et al
    The impact of benralizumab and dupilumab on exhaled volatile organic compound profiles of severe asthma patients - a preliminary analysis.
    Respir Med. 2026;262:109067.
    PubMed         Abstract available
    
    
24. BONATO M, Favero E, Ciresi M, Marcon E, et al
    De-escalation of inhaled corticosteroids and other maintenance asthma therapies in dupilumab-treated patients with severe asthma: a real-world study.
    Respir Med. 2026;261:109076.
    PubMed         Abstract available
    
    

    
    Respir Res

25. LEE YJ, Kang HR, Kim SH, Kim HJ, et al
    Blood viscosity is associated with smoking status rather than the presence of chronic obstructive pulmonary disease: findings from the Korea COPD Subgroup Study (KOCOSS).
    Respir Res. 2026;27:300.
    PubMed         Abstract available
    
    

    
    Rev Mal Respir

26. DEBRAY MP, Taille C
    [The key role of chest CT in severe asthma phenotyping].
    Rev Mal Respir. 2026 Aug 7:S0761-8425(26)00041-0. doi: 10.1016/j.rmr.2026.
    PubMed         Abstract available
    
    

    
    Thorax

27. TSIAVIA T, Henny J, Frealle E, Goldberg M, et al
    Visible mould and blood inflammatory phenotypes of asthma in adults: the CONSTANCES cohort.
    Thorax. 2026 Aug 7:thorax-2026-225328. doi: 10.1136/thorax-2026-225328.
    PubMed         Abstract available
    
    
28. MCCHRYSTAL R, McLeese RH, O'Neill B, McAuley DF, et al
    Unsupervised home spirometry versus supervised clinic spirometry: analysis of longitudinal participant-level data from the CLEAR trial in patients with bronchiectasis.
    Thorax. 2026 Aug 5:thorax-2026-225189. doi: 10.1136/thorax-2026-225189.
    PubMed         Abstract available
    
    
29. MCLEESE RH, O'Neill B, McAuley DF, Clarke M, et al
    Implementation and outcomes of drug response assessments for inhaled hypertonic saline in bronchiectasis: a post hoc analysis of the CLEAR trial.
    Thorax. 2026 Aug 5:thorax-2025-224572. doi: 10.1136/thorax-2025-224572.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum